RayPilot HypoCath_ Next Generation real-time tumor tracking for radiotherapy against prostate cancer
| Reference number | |
| Coordinator | MICROPOS MEDICAL AB (PUBL) - Micropos Medical AB |
| Funding from Vinnova | SEK 500 000 |
| Project duration | December 2018 - May 2019 |
| Status | Completed |
Important results from the project
Phase II application is completed, submitted and evaluated by the EU Commission. Obtained 13.42 points (threshold 13) but became rejected to proceed in the process. A new revised Phase II application is expected to be submitted at the beginning of June 2019.
Expected long term effects
Phase II application is completed, submitted and evaluated by the EU Commission. Obtained 13.42 points (threshold) but became rejected to proceed in the process. A new revised Phase II application is expected to be submitted at the beginning of June 2019.
Approach and implementation
Analysis for a revised new application is underway with the aim of submitting a new application at the beginning of June 2019.